| RS797044578 |
GFAP
|
Health Risk |
Pathogenic |
Alexander disease, Alexander disease |
| RS797044579 |
GFAP
|
Health Risk |
Pathogenic |
Alexander disease, Alexander disease |
| RS797044581 |
GFAP
|
Health Risk |
Pathogenic |
Alexander disease, Alexander disease |
| RS797044582 |
GFAP
|
Health Risk |
Pathogenic |
Alexander disease, Alexander disease |
| RS797044588 |
GFAP
|
Health Risk |
Pathogenic |
Alexander disease, Alexander disease |
| RS797044590 |
GFAP
|
Health Risk |
Pathogenic/Likely pathogenic |
Alexander disease, Alexander disease |
| RS797044592 |
GFAP
|
Health Risk |
Pathogenic |
Alexander disease, Alexander disease |
| RS797044593 |
MAP2K1
|
Health Risk |
Likely pathogenic |
Cardiofaciocutaneous syndrome 3, RASopathy |
| RS797044594 |
TARDBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 10, FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS |
| RS797044600 |
MYH7
|
Health Risk |
Likely pathogenic |
— |
| RS797044603 |
TREM2
|
Health Risk |
Pathogenic |
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1, Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 |
| RS797044604 |
CEP290
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 10, Bardet-Biedl syndrome |
| RS797044605 |
LRPPRC
|
Health Risk |
Pathogenic |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS797044606 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS797044607 |
PKHD1
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS797044608 |
SACS
|
Health Risk |
Likely pathogenic |
Charlevoix-Saguenay spastic ataxia, Charlevoix-Saguenay spastic ataxia |
| RS797044609 |
SLC3A1
|
Health Risk |
Likely pathogenic |
Cystinuria, Cystinuria |
| RS797044610 |
ABCD1
|
Health Risk |
Likely pathogenic |
Adrenoleukodystrophy, Inborn genetic diseases |
| RS797044611 |
ABCD1
|
Health Risk |
Likely pathogenic |
— |
| RS797044613 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Cardiovascular phenotype |
| RS797044620 |
SELENON
|
Health Risk |
Pathogenic |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS797044621 |
SELENON
|
Health Risk |
Pathogenic |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS797044623 |
CCM2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebral cavernous malformation 2, CCM2-related disorder |
| RS797044625 |
ABCD1
|
Health Risk |
Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS797044626 |
ABCD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS797044627 |
PAX6
|
Health Risk |
Pathogenic |
— |
| RS797044630 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS797044631 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS797044632 |
BBS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 2, Bardet-Biedl syndrome 2 |
| RS797044633 |
ACAT1
|
Health Risk |
Pathogenic |
— |
| RS797044636 |
CC2D2A
|
Health Risk |
Pathogenic |
— |
| RS797044638 |
SH3PXD2B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS797044642 |
PAX6
|
Health Risk |
Pathogenic |
— |
| RS797044643 |
LAMA2
|
Health Risk |
Pathogenic |
— |
| RS797044644 |
HEXB
|
Health Risk |
Pathogenic |
Sandhoff disease, Sandhoff disease |
| RS797044647 |
BCOR
|
Health Risk |
Pathogenic |
— |
| RS797044649 |
RB1
|
Health Risk |
Pathogenic |
— |
| RS797044651 |
PHF8
|
Health Risk |
Conflicting classifications of pathogenicity |
Syndromic X-linked intellectual disability Siderius type, Syndromic X-linked intellectual disability Siderius type |
| RS797044652 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Inborn genetic diseases |
| RS797044658 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1B, Usher syndrome type 1B |
| RS797044663 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS797044665 |
PHF8
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS797044667 |
ANO5
|
Health Risk |
Pathogenic |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS797044669 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS797044670 |
GLA
|
Health Risk |
Pathogenic |
— |
| RS797044671 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS797044675 |
NKX2-5
|
Health Risk |
Pathogenic |
— |
| RS797044676 |
CACNA1F
|
Health Risk |
Pathogenic |
Aland island eye disease, Retinal dystrophy |
| RS797044677 |
CHRNG
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Autosomal recessive multiple pterygium syndrome |
| RS797044680 |
MAN2B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of alpha-mannosidase, Deficiency of alpha-mannosidase |
| RS797044682 |
KDM5C
|
Health Risk |
Pathogenic |
— |
| RS797044683 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS797044684 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Heterotopia, periventricular |
| RS797044690 |
FLNA
|
Health Risk |
Pathogenic |
— |
| RS797044691 |
RTTN
|
Health Risk |
Likely pathogenic |
— |
| RS797044692 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS797044693 |
CNGB1
|
Health Risk |
Pathogenic |
— |
| RS797044695 |
KDM5C
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS797044696 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS797044697 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS797044702 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Cardiovascular phenotype |
| RS797044703 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS797044706 |
KDM5C
|
Health Risk |
Pathogenic |
— |
| RS797044709 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS797044712 |
COG7
|
Health Risk |
Pathogenic |
COG7 congenital disorder of glycosylation, COG7 congenital disorder of glycosylation |
| RS797044713 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, Polycystic kidney disease 4 |
| RS797044714 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS797044723 |
ATRX
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS797044724 |
FLNA
|
Health Risk |
Pathogenic |
— |
| RS797044725 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS797044726 |
ABCD1
|
Health Risk |
Pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS797044727 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS797044728 |
LAMA2
|
Health Risk |
Pathogenic |
— |
| RS797044729 |
PCCB
|
Health Risk |
Pathogenic |
— |
| RS797044730 |
ACTG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Autosomal dominant nonsyndromic hearing loss 20 |
| RS797044731 |
KDM5C
|
Health Risk |
Pathogenic |
— |
| RS797044733 |
MECP2
|
Health Risk |
Pathogenic |
— |
| RS797044735 |
RP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS797044739 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Melnick-Needles syndrome |
| RS797044740 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS797044743 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS797044744 |
KMT2D
|
Health Risk |
Pathogenic |
— |
| RS797044745 |
PKHD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS797044746 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Fabry disease |
| RS797044747 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS797044748 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Fabry disease |
| RS797044749 |
GLA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fabry disease, Cardiovascular phenotype |
| RS797044750 |
IDS
|
Health Risk |
Pathogenic |
— |
| RS797044751 |
NAGLU
|
Health Risk |
Pathogenic |
— |
| RS797044752 |
IQSEC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked 1 |
| RS797044753 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Melnick-Needles syndrome, Heterotopia |
| RS797044754 |
MMP13
|
Health Risk |
Pathogenic/Likely pathogenic |
MMP13-related disorder, MMP13-related disorder |
| RS797044755 |
RGS9
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS797044756 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS797044758 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS797044761 |
RDH12
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Leber congenital amaurosis 13 |
| RS797044762 |
PEX10
|
Health Risk |
Pathogenic |
— |
| RS797044764 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS797044768 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS797044769 |
GLA
|
Health Risk |
Pathogenic |
— |